Author

J. Martino

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Brown· 1 shared B. Van Houten· 1 shared C. Garro· 1 shared C. Smith· 1 shared G. Drewes· 1 shared G. Soria· 1 shared H. L. Rein· 1 shared I. Gloger· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Brown

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The human Shu complex promotes RAD51 activity by modulating RPA dynamics on ssDNA.

S. R. Hengel, K. Oppenheimer, C. Smith, M. Schaich, H. L. Rein, J. Martino, K. Darrah, O. C. Ezekwenna, K. R. Burton, B. Van Houten, M. Spies, K. A. Bernstein

This study shows the Shu complex enhances RAD51 activity by stabilizing filaments and promoting RPA diffusion on ssDNA, with implications for cancer therapy.

bioRxiv · Feb 14, 2024Biochemistry

Inhibitors of ROCK kinases induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells

J. Martino, S. O. Siri, N. S. Paviolo, C. Garro, M. F. Pansa, S. Carbajosa, A. Brown, J. L. Bocco, I. Gloger, G. Drewes, K. P. Madauss, G. Soria, V. Gottifredi

This paper shows that ROCK kinase inhibitors induce synthetic lethality in BRCA2-deficient cells through mitotic defects, independent of DNA damage.

bioRxiv · Jun 24, 2022Cancer Biology